These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8185483)

  • 21. Ultrapure dialysis fluid--direct and indirect benefits in dialysis therapy.
    Ledebo I
    Blood Purif; 2004; 22 Suppl 2():20-5. PubMed ID: 15655318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic and intradialytic effects of high-flux hemodialysis on tumor necrosis factor-alpha production: relationship to endotoxins.
    Mege JL; Sanguedolce MV; Purgus R; Moulin B; Bongrand P; Capo C; Olmer M
    Am J Kidney Dis; 1992 Nov; 20(5):482-8. PubMed ID: 1279968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring the microbiological quality of dialysate and treated water.
    Asserraji M; Maoujoud A; Belarbi M; Elfarouki R
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):91-5. PubMed ID: 24434388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience in using thermal disinfection to remove viable bacteria and endotoxins in centraly distributed reverse osmosis water.
    Alayoud A; Hamzi MA; Razkaoui A; Benyahia M
    Arab J Nephrol Transplant; 2014 Jan; 7(1):27-31. PubMed ID: 24702531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma.
    Geremia I; Bansal R; Stamatialis D
    Acta Biomater; 2019 May; 90():100-111. PubMed ID: 30953798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of bacteria in dialysate and its antibody in long-term hemodialysis patients.
    Yamagami S; Adachi T; Sugimura T; Kishimoto T; Maekawa M; Niwa M; Shaldon S
    ASAIO Trans; 1989; 35(3):331-3. PubMed ID: 2597475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Removal of lipid A and Pseudomonas aeruginosa endotoxin from dialysis fluids by high-flux polysulfone ultrafilter (dialyzer).
    Rafiee-Tehrani M; Farrokhnia R; Falkenhagen D; Weber C
    PDA J Pharm Sci Technol; 1996; 50(5):306-10. PubMed ID: 8973116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
    Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
    BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbial and endotoxin contamination in water and dialysate in the central United States.
    Klein E; Pass T; Harding GB; Wright R; Million C
    Artif Organs; 1990 Apr; 14(2):85-94. PubMed ID: 2350260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
    Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
    Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysate contamination and back filtration may limit the use of high-flux dialysis membranes.
    Baurmeister U; Travers M; Vienken J; Harding G; Million C; Klein E; Pass T; Wright R
    ASAIO Trans; 1989; 35(3):519-22. PubMed ID: 2597523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of endotoxin-contaminated dialysate and polysulfone or cellulosic membranes on the release of TNF alpha during simulated dialysis.
    Arduino MJ; Bland LA; McAllister SK; Favero MS
    Artif Organs; 1995 Sep; 19(9):880-6. PubMed ID: 8687293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin, endotoxin, and tumor necrosis factor in CAPD dialysate.
    Snitkoff G; Bailie GR; Eisele G
    Perit Dial Int; 1995; 15(6):279-80. PubMed ID: 7578513
    [No Abstract]   [Full Text] [Related]  

  • 34. High-flux dialyzers, backfiltration, and dialysis fluid quality.
    Schiffl H
    Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efforts to reduce the endotoxin levels in dialysate.
    Takamiya T
    Contrib Nephrol; 1994; 108():46-52. PubMed ID: 8039397
    [No Abstract]   [Full Text] [Related]  

  • 36. The performance evaluation of endotoxin retentive filters in haemodialysis.
    Kashiwagi T; Sato K; Kawakami S; Kiyomoto M; Takei H; Suzuki T; Genei H; Nakata H; Iino Y; Katayama Y
    J Nippon Med Sch; 2011; 78(4):214-23. PubMed ID: 21869555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leakage of Endotoxins through the Endotoxin Retentive Filter: An in vitro Study.
    Nozaki H; Tange Y; Inada Y; Uchino T; Azuma N
    Blood Purif; 2022; 51(10):831-839. PubMed ID: 35021168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contamination of dialysis water and dialysate. A survey of 30 centers.
    Bambauer R; Schauer M; Jung WK; Daum V; Vienken J
    ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
    Kumano K; Yokota S; Nanbu M; Sakai T
    Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study on the endotoxin and bacterial contamination in reverse osmosis water and dialysis fluids].
    Liu H; Li G; Zhang X; Duan X; Yao Y
    Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):806-9. PubMed ID: 11798721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.